COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,626 Articles (22,913 medRxiv, 8,713 bioRxiv)

Most recent first Previous |  Page 2481: Articles 24801-24810  | Next

Cell type-specific immune dysregulation in severely ill COVID-19 patients
Yao, C., Bora, S. A., Parimon, T., Zaman, T., Friedman, O. A., Palatinus, J. A., Surapaneni, N. S., Matusov, Y. P., Cerro Chiang, G., Kassar, A. G., Patel, N., Green, C. E., Aziz, A. W., Suri, H., Suda, J., Lopez, A. A., Martins, G. A., Stripp, B. R., Gharib, S. A., Goodridge, H. S., Chen, P.
10.1101/2020.07.23.20161182 — Posted: 2020-07-24
Rhythmic components of COVID-19 daily cases in various countries
Drozdov, A. V., Zenchenko, T. A.
10.1101/2020.07.23.20161240 — Posted: 2020-07-24
Distributional challenges regarding data on death and incidences during the SARS-CoV-2 pandemic up to July 2020
Manz, K., Mansmann, U.
10.1101/2020.07.24.20161257 — Posted: 2020-07-24
Overweight/obesity as the potentially most important lifestyle factor associated with signs of pneumonia in COVID-19
Sacco, V., Rauch, B., Gar, C., Haschka, S., Potzel, A. L., Kern-Matschilles, S., Banning, F., Benz, I., Meisel, M., Seissler, J., Lechner, A.
10.1101/2020.07.23.20161042 — Posted: 2020-07-24
COVID-19 Intensive Care Admissions Have Twice the Corrected Mortality of non-COVID-19 Viral Pneumonia
Nicolau, D. V., Hasson, A.
10.1101/2020.07.23.20161059 — Posted: 2020-07-24 Discussion: Offsite
High variation expected in the pace and burden of SARS-CoV-2 outbreaks across sub-Saharan Africa
Rice, B. L., Annapragada, A. V., Baker, R. E., Bruijning, M., Dotse-Gborgbortsi, W., Mensah, K., Miller, I. F., Motaze, N. V., Raherinandrasana, A., Rajeev, M., Rakotonirina, J., Ramiadantsoa, T., Rasambainarivo, F., Yu, W., Grenfell, B. T., Tatem, A. J., Metcalf, C. J. E.
10.1101/2020.07.23.20161208 — Posted: 2020-07-24
Model-free estimation of COVID-19 transmission dynamics from a complete outbreak
James, A., Plank, M. J., Hendy, S., Binny, R. N., Lustig, A., Steyn, N.
10.1101/2020.07.21.20159335 — Posted: 2020-07-24 Discussion: Onsite
Initial Experience in Predicting the Risk of Hospitalization of 496 Outpatients with COVID-19 Using a Telemedicine Risk Assessment Tool
O'Keefe, J. B., Tong, E. J., Taylor, T. H., Datoo O'Keefe, G. D., Tong, D. C.
10.1101/2020.07.21.20159384 — Posted: 2020-07-24
Comparative Evaluation of 19 Reverse Transcription Loop-Mediated Isothermal Amplification Assays for Detection of SARS-CoV-2
Dong, Y., Wu, X., Li, S., Lu, R., Wan, Z., Qin, J., Yu, G., Jin, X., Zhang, C.
10.1101/2020.07.22.20159525 — Posted: 2020-07-24
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
Wu, J., Liang, B., Chen, C., Wang, H., Fang, Y., Shen, S., Yang, X., Wang, B., Chen, L., Chen, Q., Wu, Y., Liu, J., Yang, X., Li, W., Zhu, B., Zhou, W., Wang, H., Li, S., Lu, S., Liu, D., Li, H., Krawczyk, A., Lu, M., Yang, D., Deng, F., Dittmer, U., Trilling, M., Zheng, X.
10.1101/2020.07.21.20159178 — Posted: 2020-07-24 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).